Bionano Genomics announced its 2024 Symposium lineup of 33 oral presentations delivered by 26 different customers worldwide featuring the utility of optical genome mapping across a wide range of research applications in cancer, cell and gene therapy, and genetic disease. 2024 Symposium will take place virtually from January 22 to 25, 2024. During these four days, customers will showcase their latest research findings using OGM. Each day will feature user presentations, a live panel with Q&A, and scientific posters within the virtual exhibition hall. On day 2, Bionano will unveil a new product expected to advance cytogenetics and structural variant analysis.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BNGO:
- Bionano announces study results in support of establishing OGM as SOC
- Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing
- Bionano Genomics announces 2024 Symposium
- Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications
- Bionano Genomics sees FY23 revenue $35.8M-$36.1M, consensus $35.94M
